EPVCoV-19 / EpiVax - LARVOL DELTA

EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics (PRNewswire) - "EpiVax, Inc....today announced it has out-licensed its COVID-19 vaccine candidate, EPV-CoV-19, to EpiVax Therapeutics....With in-licensing the COVID-19 vaccine program, EVT is broadening its pipeline and application of its platform....Having received a positive pre-IND response from the FDA, EVT is progressing to a clinical trial. It has begun GMP peptide production and is preparing the IND submission in parallel."

Licensing / partnership • Infectious Disease • Novel Coronavirus Disease